Abstract
A novel myosin heavy chain 7 mutation (E848G) identified in a familial cardiomyopathy was studied in patient-specific induced pluripotent stem cell–derived cardiomyocytes. The cardiomyopathic human induced pluripotent stem cell–derived cardiomyocytes exhibited reduced contractile function as single cells and engineered heart tissues, and genome-edited isogenic cells confirmed the pathogenic nature of the E848G mutation. Reduced contractility may result from impaired interaction between myosin heavy chain 7 and cardiac myosin binding protein C.
Original language | English (US) |
---|---|
Pages (from-to) | 728-740 |
Number of pages | 13 |
Journal | JACC: Basic to Translational Science |
Volume | 3 |
Issue number | 6 |
DOIs | |
State | Published - Dec 2018 |
Externally published | Yes |
Keywords
- disease-modeling
- engineered heart tissue
- genetic cardiomyopathy
- induced pluripotent stem cells
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine